Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» January 2011
January 2011
Myriad Test May Pinpoint Tumor Drug Success After Sanofi Medicine Failed
Myriad Test May Pinpoint Tumor Drug Success After Sanofi Medicine Failed
Bloomberg
Myriad Genetics
Johnson & Johnson Told to Pay New Jersey Doctor $482 Million Over Patent
Johnson & Johnson Told to Pay New Jersey Doctor $482 Million Over Patent
Bloomberg
JNJ
lawsuits
Endocyte plans to raise about $78 million in IPO
Endocyte plans to raise about $78 million in IPO
Yahoo/AP
Endocyte
A Busy Week For Novartis
A Busy Week For Novartis
Yahoo/CNBC
Novartis
Bionovo announces pricing of $30M offering
Bionovo announces pricing of $30M offering
bizjournals.com
Bionovo
Just One Stock: The Biopharma Veteran Facing a Landmark Stem Cell Trial
Just One Stock: The Biopharma Veteran Facing a Landmark Stem Cell Trial
Seeking Alpha
Geron
stem cells
Value Investing, Biotech Style
Value Investing, Biotech Style
Motley Fool
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
Arena's Obese To-Do List
Arena's Obese To-Do List
Motley Fool
Arena Pharmaceuticals
Qnexa
Vivus
BioTime acquires biotech company assets for $250K
BioTime acquires biotech company assets for $250K
Yahoo/AP
BioTime
Cell Targeting
OncoCyte Corp
AVEO Pharmaceuticals Shares Plunged: What You Need to Know
AVEO Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Aveo Pharmaceutical
investors
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »